Topic
HER2-Positive Metastatic Breast Cancer
3 Podcasts on BackTable
Hear how experienced physicians manage HER2-Positive Metastatic Breast Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 81 • 15 Sept 2026
CNS Disease in Breast Cancer: Clinical Management & Strategies
How should a breast cancer team manage central nervous system (CNS) disease now that systemic therapy, radiation, and surgery all compete for the first move? On this episode of BackTable Tumor Board, host Dr. Lindsay Peterson interviews Dr. Barbara O'Brien, neuro-oncologist at MD Anderson, about diagnosis, sequencing, and follow-up for CNS disease in breast cancer. They discuss risk by subtype, when to image and screen, and the importance of multidisciplinary workup for new brain metastases, as well as how to choose and sequence local and systemic options.
More on HER2-Positive Metastatic Breast Cancer
Loading recent podcasts…
Tumor Board # 81
Sep 14, 2026
with Dr. Barbara O'Brien, Dr. Lindsay Peterson
How should a breast cancer team manage central nervous system (CNS) disease now that systemic therapy, radiation, and...
Tumor Board # 48
Feb 16, 2026
with Dr. Erika Hamilton, Dr. Lindsay Peterson
In a patient with metastatic HER2-positive breast cancer, what should guide the next decision: trial data, toxicity, or...
1,700+ listens
Tumor Board # 52
Mar 23, 2026
with Dr. Sara Nunnery, Dr. Kate Baker
Antibody-drug conjugates (ADCs) are expanding treatment options in breast cancer, but their use requires careful...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.